pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda recalls·5h ago·1 min read
save

Dreyer’s Grand Ice Cream voluntarily recalls select Outshine Fruit Bars over possible glass contamination

Aug 18, 2026·read at fda recalls ↗CRLNegative

Dreyer’s Grand Ice Cream announced a voluntary recall of certain Outshine Fruit Bars after detecting possible foreign material contamination.

The recall includes Strawberry, Watermelon, Grape, Tangerine and Black Cherry flavors in 6-count 2.5-ounce packs as well as the 24-count variety pack, all due to potential glass fragments.

Affected lots are identified by batch codes LLA616903 through LLA621603 with best-before dates from September to November 2027 and were distributed to retailers nationwide. Consumers should verify UPCs and return or discard the products.

source

This writeup was produced by pharmadog from original reporting by fda recalls.

Original headline: “Updated – Dreyer’s Grand Ice Cream, Inc. Issues Voluntary Recall on Select Outshine Fruit Bars Due to Possible Foreign Matter Contamination”

read at fda recalls ↗
681 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Recall5

related stories

  • Jul 24STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and moreSTAT
  • Jul 21Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challengeFierce Biotech
  • Jul 21STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreSTAT
  • Jul 21A renewed push from the right against abortion pillsSTAT
  • Jul 20FDA still focused on lettuce supplier as source of parasite, despite faulty test resultSTAT